주식회사분자와물질
주식회사분자와물질's KOBDi Score is 42.19 as of Sep 2026, up 2.92 points since Apr 2025; it rose in 3 of the 12 monthly updates and never fell. As of Sep 2026 it is ahead of about 52% of companies in its industry, against 52% in Aug 2026 and 19% in Apr 2025. Its strongest position was 55% (Feb 2026) and its weakest 19% (Jul 2025).
A year earlier, in Aug 2025, its score was 42.03 and it was ahead of about 25% of companies in its industry.
| Sep 2026 | 42.19 | ahead of 52% |
| Aug 2026 | 42.19 | ahead of 52% |
| Jul 2026 | 42.19 | ahead of 52% |
| Jun 2026 | 42.03 | ahead of 52% |
| May 2026 | 42.03 | ahead of 53% |
| Apr 2026 | 42.03 | ahead of 53% |
| Mar 2026 | 42.03 | ahead of 53% |
| Feb 2026 | 42.03 | ahead of 55% |
| Dec 2025 | 42.03 | ahead of 55% |
| Aug 2025 | 42.03 | ahead of 25% |
| Jul 2025 | 39.42 | ahead of 19% |
| May 2025 | 39.26 | ahead of 22% |
| Apr 2025 | 39.26 | ahead of 19% |
Where is 주식회사분자와물질 located?
주식회사분자와물질 is registered at 대전 유성구 테크노4로, South Korea (postal code 34013).
What industry is 주식회사분자와물질 in?
주식회사분자와물질 belongs to Manufacturing › Pharmaceuticals & Biologics › Manufacturing of medicinal compounds and antibiotics.
How many employees does 주식회사분자와물질 have?
주식회사분자와물질 has 1–4 employees.
What is 주식회사분자와물질's KOBDi Score?
42.19 as of September 2026, ahead of about 52% of companies in its industry.
Who are 주식회사분자와물질's competitors?
Similar companies include Esmed, 주식회사리아나 and FM Agtech.

